
Urologist Peter Black, MD, discusses the recent FDA approval of atezolizumab (TECENTRIQ) for the most common form of bladder cancer as well as a complementary diagnostic test.

Urologist Peter Black, MD, discusses the recent FDA approval of atezolizumab (TECENTRIQ) for the most common form of bladder cancer as well as a complementary diagnostic test.

In this video, Neil Baum, MD, compares UroLift with other BPH management strategies and also discusses his experience with the use of nitrous oxide as an effective sedative during in-office urologic procedures.

This video demonstrates UroLift placement under topical anesthesia in the office setting and also includes comments from several patients who underwent the procedure.

This video provides an overview of the prostatic urethral lift (UroLift), highlighting the entire cycle of patient care.



Although there is no clear-cut solution to the problem of recurrent UTIs in postmenopausal women, "various strategies can be employed that have found success," write Wade Bushman, MD, PhD, and Brian V. Le, MD, MA.

Urologists and other physicians who serve Medicare patients face some new decisions now that the Centers for Medicare & Medicaid Services has proposed new regulations implementing last year’s fee schedule reform law, while also replacing the existing meaningful use program with a more flexible approach to technology and electronic health records.

One of the greatest benefits of being covered under a high-deductible health plan is generally the ability to open a health savings account and receive tax-preferred treatment on money saved for medical expenses.

“Few physicians are familiar with apology law and even fewer understand the significance,” said Patrick McKenna, MD, chief of the division of pediatric urology at American Family Children’s Hospital and professor of urology at the University of Wisconsin, Madison.

Expression of androgen receptor splice variant 7 (AR-V7) in whole blood predicts worse cancer-related outcomes in patients with metastatic castration-resistant prostate cancer who are treated with abiraterone acetate (ZYTIGA).

"What the AUA can do for those of us in the trenches, so to speak, is to lessen some of the regulatory burdens that have been put on us," says one urologist.

In a series of articles this year, Robert A. Dowling, MD, will examine what you need to know about the law, what the CMS proposed rule for implementation implies for the near and long-term future, and-when it is issued later this year-what the final rule means to your urology practice.

"With all this uncertainty, the good news is that men will no longer need to travel to Canada or elsewhere for prostate HIFU therapy," writes Leonard G. Gomella, MD.

The Centers for Medicare & Medicaid Services (CMS) has released a proposed rule regarding the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. This article will summarize some of the details of the proposed rule, including an outline of the Merit-Based Incentive Payment System (MIPS), one of the key components of MACRA.

Expert urologists offer time-saving techniques for artificial sphincter insertion.

Our coverage of the 2016 AUA annual meeting includes articles on stone disease, prostate cancer, Peyronie’s disease, and more.

The ACA is a large step forward in allowing men to embrace their health concerns, and for health care practitioners to understand men and the challenge of help seeking, masculinity, and disparity in their quest for wellness (Men’s Health in Primary Care [Current Clinical Practice]. Switzerland: Springer International Publishing, 2016).

Evaluation of the InterStim system in patients with urgency incontinence, urgency frequency, or both suggests benefits beyond urinary symptom relief.

In a study of intralesional collagenase clostridium histolyticum, mean curvature was reduced most dramatically after the first cycle, researchers reported.

A recent study provides the first comprehensive catalog of urinary calcium oxalate monohydrate binding proteins.

The procedure maximally preserves normal renal parenchyma and provides better surgical precision than standard partial nephrectomy, researchers report.

Researchers looking to create a shared decision-making tool identify 13 major themes when interviewing parents of children with VUR.

Paradoxically, the authors of a large study did not find a negative effect in functional outcomes analyzed.

Transrectal HIFU shows a statistically significant increase in per-core negative biopsy rates.

Researchers from the Endourology Disease Group for Excellence research consortium compared the techniques in 152 patients at several stone centers.

Trends in percutaneous nephrolithotomy may reflect other stone treatment trends, study authors say.

A CMS quality measure needs to be bidirectional, “specifying a rate of observation for low-risk disease and a rate of treatment for high-risk disease,” researchers say.

An image-guided technique for treating LUTS associated with BPH is reproducible and promising, researchers say.